Home > PB Ratio > BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
PB (Price/Book ) Ratio

The Current P/B Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is 1.45.

Share Price ₹29.6Apr 23,2024
Market Cap ₹128.0 Cr
Book Value₹88.2 CrMar2023 - Standalone Results
Price/Book 1.45xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
Please provide your vote to see the results

Definition & Calculation of PB (Price/Book ) ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is calculated as :

Current Market Cap [ ₹128.0 Cr] as on Apr 23,2024

(/) Book Value [ ₹88.2 Cr] based on Mar2023 - Standalone Results

(=) P/B Ratio [ 1.45x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION , the investors are currently willing to pay '1.45 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION !

The chart below summarizes the trend in P/B Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION over the last five years.

Historical PB (Price/Book ) ratio chart of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION


PB Ratio Performance Analysis for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's latest p/b ratio is 1.45x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 12.48x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's operated at median p/b ratio of 1.08x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/b ratio peaked in Mar2021 at 83.21x.

- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/b ratio hit its five-year low in Mar2022 of -18.98x.


How does BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 88.211.45128.0
SUN PHARMACEUTICAL INDUSTRIES LTD55,995.406.36356,001.0
CIPLA LTD23,346.004.66108,813.0
DR REDDYS LABORATORIES LTD23,140.404.2999,325.3
ZYDUS LIFESCIENCES LTD17,515.805.5196,553.2
DIVIS LABORATORIES LTD12,767.107.84100,075.0
MANKIND PHARMA LTD7,435.1612.9095,896.9
TORRENT PHARMACEUTICALS LTD6,198.0714.4089,224.4
LUPIN LTD12,315.605.8572,033.6
AUROBINDO PHARMA LTD26,839.802.3964,043.1
ABBOTT INDIA LTD3,146.0217.3954,704.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 1.45x
Max industry PB 17.39x
Median industry PB 5.85x
Average industry PB 7.55x



You may also like the below Video Courses